Unfortunately, there is significant evidence to suggest that one of the most popular third-party testing labs does not use scientifically sound methodologies and, in some cases, has fabricated results
One trial showed that two-thirds of patients on once-weekly semaglutide 2.4 mg (Wegovy, Novo Nordisk) regained their weight 1 year after stopping the medication
PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 49 peptides, including key appetite-regulation variants like GLP1R rs6923761 and FTO rs9939609
A documented taper plan if stopping is on the table, with weight, body composition, and cardiometabolic markers tracked through the taper and for at least 12 months after
As newer drugs hit the scene and more data rolls in, well get a clearer picture of how to give people with diabetes the longest, healthiest lives possible
Subgroup analysis revealed consistent results across age groups, including participants in their thirties, forties, and fifties
/assets/images/provider/photos/2680950.jpg)
